Zakaria Mohamed Adan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zakaria Mohamed Adan has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Abdullahi Abdirahman Omar
Department of Research, Dr. Sumait Hospital, SIMAD University, Mogadishu, Somalia
4 shared publications - Ibrahim Abdullahi Mohamed
Department of Anaesthesiology and Critical Care, Dr. Sumait Hospital, SIMAD University, Mogadishu, Somalia
3 shared publications Bashiru Garba
Department Public Health, Faculty of Medicine and Health Sciences of SIMAD University, Mogadishu, Somalia
2 shared publications- Mohamed Abdulahi Hassan
Department of Internal Medicine, Faculty of Medicine and Health Sciences, SIMAD University, Mogadishu, Somalia
2 shared publications - Jamal Hassan Mohamoud
Department of Public Health, Faculty of Medicine and Health Sciences, SIMAD University, Mogadishu, Somalia
1 shared publication Mariam Abdi Hassan
Dr.Sumait Hospitals, Faculty of Medicine and Health Sciences, SIMAD University, Mogadishu, Somalia
1 shared publication
Latest Publications
- Open Access
- 1 March 2026
- Published by Taylor & Francis in Journal of Multidisciplinary Healthcare
- Vol. ume 19, 1-5
Strengthening ENT Care in Low Resource Settings: Multidisciplinary and Technology Enabled Strategies to Reduce Preventable Morbidity
Ear, nose, and throat disorders remain an overlooked public health challenge in low resource settings, where shortages of trained specialists, limited diagnostic tools, and fragile health systems contribute to preventable disability. Somalia exemplifies the difficulties faced by countries affected by protracted conflict, widespread displacement, and underdeveloped healthcare infrastructure, where patients frequently present late with chronic ear infections, progressive hearing loss, airway obstruction, or advanced head and neck cancers. These challenges mirror conditions across many low and middle income countries in Africa and Asia. This commentary synthesizes published literature and institutional reports to examine the burden of ENT disease, health system gaps, and feasible strengthening strategies in Somalia and comparable low resource settings. It highlights the relevance of digital diagnostics, telemedicine, task sharing, community screening, and surgical capacity development as realistic approaches to reducing preventable morbidity in fragile health systems.
- 1 March 2026
- Published by Taylor & Francis in Journal of Multidisciplinary Healthcare
- Vol. ume 19, 1-5
Open AccessStrengthening ENT Care in Low Resource Settings: Multidisciplinary and Technology Enabled Strategies to Reduce Preventable Morbidity
Ear, nose, and throat disorders remain an overlooked public health challenge in low resource settings, where shortages of trained specialists, limited diagnostic tools, and fragile health systems contribute to preventable disability. Somalia exemplifies the difficulties faced by countries affected by protracted conflict, widespread displacement, and underdeveloped healthcare infrastructure, where patients frequently present late with chronic ear infections, progressive hearing loss, airway obstruction, or advanced head and neck cancers. These challenges mirror conditions across many low and middle income countries in Africa and Asia. This commentary synthesizes published literature and institutional reports to examine the burden of ENT disease, health system gaps, and feasible strengthening strategies in Somalia and comparable low resource settings. It highlights the relevance of digital diagnostics, telemedicine, task sharing, community screening, and surgical capacity development as realistic approaches to reducing preventable morbidity in fragile health systems.
- Open Access
- 1 May 2025
- Published by Taylor & Francis in International Medical Case Reports Journal
- Vol. ume 18, 545-551
Intracerebral Hemorrhage: A Fatal Complication of Severe Preeclampsia—A Rare Case Report in a Resource-Limited Setting
Background: Intracerebral hemorrhage (ICH) is a rare but severe complication of preeclampsia, significantly contributing to maternal morbidity and mortality, particularly in resource-limited settings. The underlying mechanisms include endothelial dysfunction, cerebral autoregulation failure, and breakdown of the blood-brain barrier. This case report aims to highlight a unique presentation of severe preeclampsia complicated by ICH, emphasizing barriers encountered in resource-limited settings and discussing long-term implications and prognosis. Case Presentation: A 35-year-old multiparous woman presented two days postpartum with altered mental status, aphasia, and right-sided hemiparesis. Her pregnancy was complicated by severe preeclampsia and intrauterine fetal death. Computed tomography (CT) revealed a left basal ganglia hemorrhage extending into the ventricles. She received conservative management including antihypertensive medications, magnesium sulfate for seizure prophylaxis, and anti-edema therapy. Despite limited diagnostic resources, laboratory evaluations ruled out coagulopathies and vascular anomalies. After 20 days of multidisciplinary care, significant neurological recovery was achieved. Follow-up after four weeks demonstrated complete functional recovery, with resolution confirmed by repeat CT. Conclusion: This case uniquely underscores the critical importance of timely multidisciplinary care and robust antenatal monitoring in mitigating severe complications such as ICH associated with preeclampsia. The patient’s full recovery highlights the potential for successful conservative management even in resource-constrained environments. Future clinical practice and research should focus on improving antenatal care accessibility, patient education, and developing context-specific management guidelines to reduce maternal morbidity and mortality in similar settings.
- 1 May 2025
- Published by Taylor & Francis in International Medical Case Reports Journal
- Vol. ume 18, 545-551
Open AccessIntracerebral Hemorrhage: A Fatal Complication of Severe Preeclampsia—A Rare Case Report in a Resource-Limited Setting
Background: Intracerebral hemorrhage (ICH) is a rare but severe complication of preeclampsia, significantly contributing to maternal morbidity and mortality, particularly in resource-limited settings. The underlying mechanisms include endothelial dysfunction, cerebral autoregulation failure, and breakdown of the blood-brain barrier. This case report aims to highlight a unique presentation of severe preeclampsia complicated by ICH, emphasizing barriers encountered in resource-limited settings and discussing long-term implications and prognosis. Case Presentation: A 35-year-old multiparous woman presented two days postpartum with altered mental status, aphasia, and right-sided hemiparesis. Her pregnancy was complicated by severe preeclampsia and intrauterine fetal death. Computed tomography (CT) revealed a left basal ganglia hemorrhage extending into the ventricles. She received conservative management including antihypertensive medications, magnesium sulfate for seizure prophylaxis, and anti-edema therapy. Despite limited diagnostic resources, laboratory evaluations ruled out coagulopathies and vascular anomalies. After 20 days of multidisciplinary care, significant neurological recovery was achieved. Follow-up after four weeks demonstrated complete functional recovery, with resolution confirmed by repeat CT. Conclusion: This case uniquely underscores the critical importance of timely multidisciplinary care and robust antenatal monitoring in mitigating severe complications such as ICH associated with preeclampsia. The patient’s full recovery highlights the potential for successful conservative management even in resource-constrained environments. Future clinical practice and research should focus on improving antenatal care accessibility, patient education, and developing context-specific management guidelines to reduce maternal morbidity and mortality in similar settings.
- Open Access
- 1 September 2024
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 17, 3879-3890
Assessment of Non-Adherence to Anti-TB Drugs and Associated Factors Among Patients Attending TB Treatment Centers During COVID-19 Pandemic in Mogadishu, Somalia: A Cross-Sectional Study
Background: The COVID-19 pandemic’s first wave and subsequent lockdowns disrupted global healthcare systems, significantly impacting essential services including tuberculosis (TB) care. Non-adherence to anti-TB drugs is a critical concern, leading to treatment failure, drug resistance, and increased morbidity and mortality. This study assessed the rate and determinants of non-adherence to TB treatment among patients at TB centers during the first wave of the pandemic. Material and Methods: A cross-sectional study was conducted from June 15 to July 30, 2020, involving 255 TB patients at three centers in Mogadishu. Data were gathered using the Morisky Medication Adherence Scale-8 (MMAS-8) through structured interviews and analyzed using descriptive statistics and binary logistic regression. Results: The study found a 34.5% non-adherence rate during the pandemic. Key reasons for non-adherence included forgetting to take medication (33%), feeling well (29%), experiencing side effects (18%), and fear of contracting COVID-19 (16%). Significant factors associated with non-adherence were age groups 25– 34 years (OR = 2.96, p = 0.024) and 35– 44 years (OR = 4.55, p = 0.005), unemployment (OR = 2.57, p = 0.037), smoking (OR = 3.49, p = 0.029), tobacco use (OR = 4.15, p = 0.034), proximity to a health facility (OR = 0.44, p = 0.033), perception of healthcare providers as very friendly (OR = 0.24, p = 0.031) or friendly (OR = 0.45, p = 0.023), being in the continuous treatment phase (OR = 3.2, p < 0.001), and experiencing adverse treatment effects (OR = 2.42, p = 0.003). Conclusion: Non-adherence to anti-tuberculosis treatment was notably high in Mogadishu during the first wave of the pandemic, necessitating targeted interventions to improve adherence.
- 1 September 2024
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 17, 3879-3890
Open AccessAssessment of Non-Adherence to Anti-TB Drugs and Associated Factors Among Patients Attending TB Treatment Centers During COVID-19 Pandemic in Mogadishu, Somalia: A Cross-Sectional Study
Background: The COVID-19 pandemic’s first wave and subsequent lockdowns disrupted global healthcare systems, significantly impacting essential services including tuberculosis (TB) care. Non-adherence to anti-TB drugs is a critical concern, leading to treatment failure, drug resistance, and increased morbidity and mortality. This study assessed the rate and determinants of non-adherence to TB treatment among patients at TB centers during the first wave of the pandemic. Material and Methods: A cross-sectional study was conducted from June 15 to July 30, 2020, involving 255 TB patients at three centers in Mogadishu. Data were gathered using the Morisky Medication Adherence Scale-8 (MMAS-8) through structured interviews and analyzed using descriptive statistics and binary logistic regression. Results: The study found a 34.5% non-adherence rate during the pandemic. Key reasons for non-adherence included forgetting to take medication (33%), feeling well (29%), experiencing side effects (18%), and fear of contracting COVID-19 (16%). Significant factors associated with non-adherence were age groups 25– 34 years (OR = 2.96, p = 0.024) and 35– 44 years (OR = 4.55, p = 0.005), unemployment (OR = 2.57, p = 0.037), smoking (OR = 3.49, p = 0.029), tobacco use (OR = 4.15, p = 0.034), proximity to a health facility (OR = 0.44, p = 0.033), perception of healthcare providers as very friendly (OR = 0.24, p = 0.031) or friendly (OR = 0.45, p = 0.023), being in the continuous treatment phase (OR = 3.2, p < 0.001), and experiencing adverse treatment effects (OR = 2.42, p = 0.003). Conclusion: Non-adherence to anti-tuberculosis treatment was notably high in Mogadishu during the first wave of the pandemic, necessitating targeted interventions to improve adherence.
- Open Access
- 1 January 2024
- Published by Taylor & Francis in Vascular Health and Risk Management
- Vol. ume 20, 21-26
Sildenafil Use and Cigarette Smoking Associated with Intracerebral Hemorrhage: A Rare Case Report
Background: Intracerebral hemorrhage (ICH) is a serious condition characterized by bleeding within the brain tissue. Although the use of sildenafil, a vasodilator agent for erectile dysfunction, has been associated with rare cases of ICH, the combination of sildenafil usage and smoking as risk factors for ICH has not yet been reported. This case report describes the occurrence of ICH in a patient with a history of both sildenafil usage and heavy smoking. Case Presentation: A 53-year-old male, with a history of smoking and regular sildenafil use, was brought to the emergency department due to loss of consciousness with right-side weakness, he initially experienced with nausea, vomiting and dizziness after taking sildenafil 100mg tablet once. The Glasgow Coma Score (GCS) was 10 with side hemiparesis. Non-contrast CT revealed left thalamic acute hemorrhage with ventricular extension. Furthermore, a head CT angiography ruled out any vascular anomalies after that the patient was admitted to the intensive care unit (ICU) for conservative management. After three days on clinical and neurological improvement, the patient was transferred to the inpatient ward for further management, monitoring and physiotherapy. On day 6, the patient was discharged and planned for flow up. Conclusion: This rare case highlights the need for further research and awareness regarding the potential risks associated with the combination of sildenafil and heavy smoking. Healthcare professionals should carefully evaluate the individual risk factors of patients, educate them about potential complications, and consider alternative treatments if necessary. Additionally, patients should be encouraged to quit smoking and adopt a healthy lifestyle to minimize the risk of cerebrovascular events.
- 1 January 2024
- Published by Taylor & Francis in Vascular Health and Risk Management
- Vol. ume 20, 21-26
Open AccessSildenafil Use and Cigarette Smoking Associated with Intracerebral Hemorrhage: A Rare Case Report
Background: Intracerebral hemorrhage (ICH) is a serious condition characterized by bleeding within the brain tissue. Although the use of sildenafil, a vasodilator agent for erectile dysfunction, has been associated with rare cases of ICH, the combination of sildenafil usage and smoking as risk factors for ICH has not yet been reported. This case report describes the occurrence of ICH in a patient with a history of both sildenafil usage and heavy smoking. Case Presentation: A 53-year-old male, with a history of smoking and regular sildenafil use, was brought to the emergency department due to loss of consciousness with right-side weakness, he initially experienced with nausea, vomiting and dizziness after taking sildenafil 100mg tablet once. The Glasgow Coma Score (GCS) was 10 with side hemiparesis. Non-contrast CT revealed left thalamic acute hemorrhage with ventricular extension. Furthermore, a head CT angiography ruled out any vascular anomalies after that the patient was admitted to the intensive care unit (ICU) for conservative management. After three days on clinical and neurological improvement, the patient was transferred to the inpatient ward for further management, monitoring and physiotherapy. On day 6, the patient was discharged and planned for flow up. Conclusion: This rare case highlights the need for further research and awareness regarding the potential risks associated with the combination of sildenafil and heavy smoking. Healthcare professionals should carefully evaluate the individual risk factors of patients, educate them about potential complications, and consider alternative treatments if necessary. Additionally, patients should be encouraged to quit smoking and adopt a healthy lifestyle to minimize the risk of cerebrovascular events.